Poster Abstract Session:
152. Herpes Zoster Vaccine
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Performance of Zoster Vaccine Live (Zostavax): A Systematic Review of 12 years of Experimental and Observational Evidence
Kathleen Dooling, MD, MPH; Angela Guo, MPH; Jessica Leung, MPH; Edward Belongia, MD; Rafael Harpaz, MD
Assessment of the Potential Herpes Zoster and Post Herpetic Neuralgia Case Avoidance with Vaccination in the United States
Brandon J. Patterson, PharmD, PhD; Philip O. Buck, PhD, MPH; Justin Carrico, BS; Katherine A. Hicks, MS; Desmond Curran, PhD; Desiree Van Oorschot, MSc; John E. Pawlowski, PhD; Bruce Y. Lee, MD, MBA; Barbara P. Yawn, MD, MSc, MSPH, FAAFP
Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
Laurie Aukes, RN; Joan Bartlett, MPH, MPP; Bruce Fireman, MA; John Hansen, MPH; Edwin Lewis, MPH; Elizabeth Earley, MPH; Morgan Marks, PhD; Patricia Saddier, MD, PhD; Nicola P. Klein, MD, PhD
  • 1339_IDWPoster_HZO.pdf (174.6 kB)
  • Immune Senescence Factors Associated with the Immunogenicity of a Live Attenuated Zoster Vaccine (ZV) in Older Adults
    Adriana Weinberg, MD, FIDSA; Kenneth Schamder, MD; Michael Johnson, BS; Zoran Popmihajlov, MD, MS; Adriana Tovar-Salazar, MS; Yupanqui Caldas, PhD; Lei Pang, PhD; Alice Cho, BS; Myron Levin, MD, FIDSA
    Humoral and Cellular Immunogenicity of Zoster Vaccine within One Year after Herpes Zoster
    Eunyoung Lee, M.D.; June Young Chun, MD; Kyoung-Ho Song, MD; Pyeong Gyun Choe, M.D.; Ji Whan Bang, MD; Eu Suk Kim, MD; Hong Bin Kim, MD, PhD; Sang Won Park, M.D., Ph.D.; Nam Joong Kim, M.D., Ph.D.; Wan Beom Park, MD; Myoung-Don Oh, M.D., Ph.D.
  • IDWEEK2017poster1341_1.pdf (314.7 kB)
  • Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial
    Katrijn Grupping, PhD; Laura Campora, MD; Martine Douha, MSc; Thomas C. Heineman, MD, PhD; Nicola P. Klein, MD, PhD; Himal Lal, MD; James Peterson, MD, FAAFP; Lidia Oostvogels, MD
  • IDW_pos_1342_web.pdf (746.3 kB)
  • Persistence of Immune Response to an Adjuvanted Varicella‐Zoster Virus Subunit Candidate Vaccine for up to Year 9 in Older Adults
    Karlis Pauksens, MD; Stephanie Volpe, MPH; Tino F. Schwarz, MD; Jan Smetana, MD Ph.D.; Nicole Toursarkissian, MD; Lars Rombo, MD; Stéphanie Ravault, PhD; Marie-Pierre David, MSc; Adriana Bastidas, PhD; Lidia Oostvogels, MD
  • IDW_pos_1343_web.pdf (1.0 MB)
  • A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
    Lesia Dropulic, M.D.; Kening Wang, M.D.; Makinna Oestreich, B.A.; Harlan Pietz, B.S.; Doreen Garabedian, BSN, RN; Sinthujan Jegaskanda, PhD; Kennichi Dowdell, PhD; Hanh Nguyen, B.S.; Kerry Laing, PhD; David Koelle, M.D.; Aaron Azose, B.S.; Sally Hunsberger, PhD; Keith Lumbard, MS; Aiying Chen, PhD; Lee-Jah Chang, MD; Sanjay Phogat, PhD; Jeffrey Cohen, M.D.
    Results of a Safety Pooled Analysis of an Adjuvanted Herpes Zoster Subunit Vaccine in More than 14,500 Participants Aged 50 Years or Older
    Marta López-Fauqued, PhD; Laura Campora, MD; Frédérique Delannois, DVM; Mohamed El Idrissi, MSc; Edouard Ledent, MSc; Javier Diez-Domingo, MD, PhD; Janet McElhaney, MD; Shelly McNeil, MD, FRCPC, FIDSA; Ferdinandus De Looze, MBBS FRACGP MSc; Wilfred Yeo, MB, ChB, MD; Fernanda Tavares Da Silva, MD, ObGvn
    Vaccination Response to an Ongoing Meningitis Outbreak: Uptake and Attitudes among Men Who Have Sex with Men in Los Angeles, CA
    Ian Holloway, PhD, MSW, MPH; Elizabeth Wu, MPH; Jennifer Gildner, MSPH; Vincent Fenimore, PhD, M.Ed.; Paula Frew, PhD, MA, MPH
    Bivalent Norovirus VLP Vaccine Candidate in Older Adults: Impact of MPL and a Second Dose in a Randomized, Controlled, Double-Blind Clinical Trial
    Jim Sherwood, BA; Jakob Cramer, MD; Nancy Bouveret Le Cam, MD; Stella Lin, PhD; Frank Baehner, MD; Paul Mendelman, MD; Astrid Borkowski, MD
  • Poster Sherwood for print.pdf (919.1 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.